Lataa...
Prevention and rescue of cardiac dysfunction by methanocarba adenosine monophosphonate derivatives
Accumulating evidence supports a therapeutic role of purinergic signaling in cardiac diseases. Previously, efficacy of systemically infused MRS2339, a charged methanocarba derivative of 2-Cl-adenosine monophosphate, was demonstrated in animal models of heart failure. We now test the hypothesis that...
Tallennettuna:
| Julkaisussa: | Purinergic Signal |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Netherlands
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7166228/ https://ncbi.nlm.nih.gov/pubmed/31989534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11302-020-09688-0 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|